Mass infection is not an option: We must do more to protect our young

Deepti Gurdasani; John Drury; Trisha Greenhalgh; Stephen Griffin; Zubaida  Haque; Zoë Hyde; Aris  Katzourakis; Martin McKee; Susan Michie; Christina Pagel; Stephen D. Reicher; Alice Roberts; Robert West; Kit Yates; Hisham Ziauddeen

doi:10.1016/S0140-6736(21)01589-0

Mass infection is not an option: We must do more to protect our young

Deepti Gurdasani, John Drury, Trisha Greenhalgh, Stephen Griffin, Zubaida Haque, Zoë Hyde, Aris Katzourakis, Martin McKee, Susan Michie, Christina Pagel, Stephen D. Reicher, Alice Roberts, Robert West, Kit Yates, Hisham Ziauddeen

Research output: Contribution to journal › Letter

28 Citations (SciVal)

125 Downloads (Pure)

Original language	English
Pages (from-to)	297-298
Number of pages	2
Journal	The Lancet
Volume	398
Issue number	10297
Early online date	7 Jul 2021
DOIs	https://doi.org/10.1016/S0140-6736(21)01589-0
Publication status	Published - 24 Jul 2021

Bibliographical note

Funding Information:
JD, ZHa, MM, SM, CP, AR, and SR are members of Independent SAGE. SR is a member of the advisory group to the Scottish Chief Medical Officer. RW, SM, SR, and JD are participants in the Independent Scientific Pandemic Insights Group on Behaviours, the behavioural science subgroup of SAGE. JD declares funding for research on public behaviour in the pandemic, paid to the University of Sussex, from the Economic and Social Research Council (ESRC) and fees from the BBC and The Guardian for media appearances and articles. SG declares research grants from the Medical Research Council (MRC) and the AMMF and fees from Hallmark Care Homes for webinars about vaccine hesitancy. SG is also a member of the UK Government's COVID-19 Expert Panel on Home Testing and the COVID-19 International Best Practice Advisory Group, and he is a consultant on shielding for the International Comparators Joint Unit (IBPAG-ICJU). SG is Chair of the Virus Division of the Microbiology Society and a member of the British Society for Antimicrobial Chemotherapy grants review panel. SM declares research grants from the MRC, the ESRC, the Wellcome Trust, Cancer Research UK, and the National Institutes of Health Research and fees from the BBC and ITN for media appearances. All other authors declare no competing interests. A summit to discuss the concerns outlined in this Correspondence will take place on July 8, 2021. Signatories of this Correspondence are listed in the appendix .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Mass infection
Herd immunity
Vaccination
COVID-19

Access to Document

10.1016/S0140-6736(21)01589-0Licence: Unspecified

mass_infection_is_not_an_optionAccepted author manuscript, 532 KBLicence: CC BY-NC

Cite this

@article{1e79daa7c22a4aff94ce6b904c70dda5,

title = "Mass infection is not an option: We must do more to protect our young",

keywords = "Mass infection, Herd immunity, Vaccination, COVID-19",

author = "Deepti Gurdasani and John Drury and Trisha Greenhalgh and Stephen Griffin and Zubaida Haque and Zo{\"e} Hyde and Aris Katzourakis and Martin McKee and Susan Michie and Christina Pagel and Reicher, \{Stephen D.\} and Alice Roberts and Robert West and Kit Yates and Hisham Ziauddeen",

note = "Funding Information: JD, ZHa, MM, SM, CP, AR, and SR are members of Independent SAGE. SR is a member of the advisory group to the Scottish Chief Medical Officer. RW, SM, SR, and JD are participants in the Independent Scientific Pandemic Insights Group on Behaviours, the behavioural science subgroup of SAGE. JD declares funding for research on public behaviour in the pandemic, paid to the University of Sussex, from the Economic and Social Research Council (ESRC) and fees from the BBC and The Guardian for media appearances and articles. SG declares research grants from the Medical Research Council (MRC) and the AMMF and fees from Hallmark Care Homes for webinars about vaccine hesitancy. SG is also a member of the UK Government's COVID-19 Expert Panel on Home Testing and the COVID-19 International Best Practice Advisory Group, and he is a consultant on shielding for the International Comparators Joint Unit (IBPAG-ICJU). SG is Chair of the Virus Division of the Microbiology Society and a member of the British Society for Antimicrobial Chemotherapy grants review panel. SM declares research grants from the MRC, the ESRC, the Wellcome Trust, Cancer Research UK, and the National Institutes of Health Research and fees from the BBC and ITN for media appearances. All other authors declare no competing interests. A summit to discuss the concerns outlined in this Correspondence will take place on July 8, 2021. Signatories of this Correspondence are listed in the appendix .",

year = "2021",

month = jul,

day = "24",

doi = "10.1016/S0140-6736(21)01589-0",

language = "English",

volume = "398",

pages = "297--298",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10297",

}

TY - JOUR

T1 - Mass infection is not an option

T2 - We must do more to protect our young

AU - Gurdasani, Deepti

AU - Drury, John

AU - Greenhalgh, Trisha

AU - Griffin, Stephen

AU - Haque, Zubaida

AU - Hyde, Zoë

AU - Katzourakis, Aris

AU - McKee, Martin

AU - Michie, Susan

AU - Pagel, Christina

AU - Reicher, Stephen D.

AU - Roberts, Alice

AU - West, Robert

AU - Yates, Kit

AU - Ziauddeen, Hisham

N1 - Funding Information: JD, ZHa, MM, SM, CP, AR, and SR are members of Independent SAGE. SR is a member of the advisory group to the Scottish Chief Medical Officer. RW, SM, SR, and JD are participants in the Independent Scientific Pandemic Insights Group on Behaviours, the behavioural science subgroup of SAGE. JD declares funding for research on public behaviour in the pandemic, paid to the University of Sussex, from the Economic and Social Research Council (ESRC) and fees from the BBC and The Guardian for media appearances and articles. SG declares research grants from the Medical Research Council (MRC) and the AMMF and fees from Hallmark Care Homes for webinars about vaccine hesitancy. SG is also a member of the UK Government's COVID-19 Expert Panel on Home Testing and the COVID-19 International Best Practice Advisory Group, and he is a consultant on shielding for the International Comparators Joint Unit (IBPAG-ICJU). SG is Chair of the Virus Division of the Microbiology Society and a member of the British Society for Antimicrobial Chemotherapy grants review panel. SM declares research grants from the MRC, the ESRC, the Wellcome Trust, Cancer Research UK, and the National Institutes of Health Research and fees from the BBC and ITN for media appearances. All other authors declare no competing interests. A summit to discuss the concerns outlined in this Correspondence will take place on July 8, 2021. Signatories of this Correspondence are listed in the appendix .

PY - 2021/7/24

Y1 - 2021/7/24

KW - Mass infection

KW - Herd immunity

KW - Vaccination

KW - COVID-19

UR - https://www.scopus.com/pages/publications/85111051682

U2 - 10.1016/S0140-6736(21)01589-0

DO - 10.1016/S0140-6736(21)01589-0

M3 - Letter

SN - 0140-6736

VL - 398

SP - 297

EP - 298

JO - The Lancet

JF - The Lancet

IS - 10297

ER -

Mass infection is not an option: We must do more to protect our young

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Cite this